Dog Dementia Supplements: What the Evidence Actually Shows

Short answer: no supplement is a treatment for dog dementia, and none has been shown to stop or reverse it. If your dog is showing signs, the first step is a veterinary appointment, not a purchase. The strongest evidence in aging dogs is for antioxidant-enriched therapeutic diets combined with behavioral enrichment, both of which run through your vet. This page exists because a lot of what is written about dog dementia supplements overstates the evidence, and we would rather be the page that does not.

Understanding dog dementia

Canine cognitive dysfunction (CCD) is a neurodegenerative condition with similarities to Alzheimer's disease in humans. It affects older dogs, typically those over seven, and involves gradual decline in memory, learning and awareness. The cause is not fully understood, but brain aging, oxidative stress and the accumulation of beta-amyloid plaques are all implicated.

Common signs include:

• Disorientation and confusion in familiar places
• Changes in sleep-wake cycles
• Loss of housetraining
• Decreased interaction with family members
• Anxiety and restlessness

These signs are not specific to dementia. Pain, hearing or vision loss, hypertension, thyroid and adrenal disease, and brain lesions can all produce the same picture, and several of those are treatable. CCD is a diagnosis of exclusion, which is exactly why the veterinary appointment comes before anything else. Getting the diagnosis wrong means missing something you could have fixed.

What has actual evidence in aging dogs

This is a short list, and that is the honest state of the field.

Antioxidant-enriched therapeutic diets

This is the strongest canine evidence in the area. In controlled studies in aged beagles, diets enriched with antioxidants improved performance on cognitive tasks compared with control diets, and the effect was larger when combined with behavioral enrichment. These are prescription therapeutic diets obtained through a veterinarian, not shelf supplements, and the trials tested the whole diet rather than any single ingredient pulled out of it.

Enrichment, routine and exercise

In the same body of work, behavioral enrichment added measurably to the dietary effect. Mental stimulation through puzzle toys and training, regular physical exercise, a consistent daily routine that reduces confusion, and a safe familiar environment are all supported, cost nothing, and carry no risk.

Prescription medication

There is a licensed veterinary medication for CCD in dogs. Whether it is appropriate is a clinical decision for your vet, and it is a conversation worth having early rather than after months of trying supplements.

Where the evidence is weaker than the marketing

Several ingredients are widely sold for canine cognition on the strength of human, rodent or laboratory data rather than canine outcome trials. Omega-3 fatty acids, SAMe, phosphatidylserine and various antioxidant blends all appear in this category. Some are plausible, some are well tolerated, and none of them has canine evidence approaching what the therapeutic diets have. If a product page tells you an ingredient improves memory in dogs, ask which trial in dogs it is pointing to.

NAD+ precursors and dementia: our own product

We sell an NAD+ precursor, so this section is where we have the clearest conflict of interest, and it is the section we most want you to read.

No published canine study shows an NAD+ precursor improving cognition. The single canine trial usually cited tested a senolytic combined with an NAD+ precursor, did not measure NAD+ at all, and its objective cognitive testing showed no significant difference. Only the owner-completed questionnaire moved, and the trial was funded by the product's maker. On the human side, all three nicotinamide riboside trials that measured cognition were null, at five to ten times the dose used in dog products.

So LongTails NAD+ Precursor is not a dementia product and we will not sell it as one. What the evidence supports is the mechanism: NAD+ is required for cellular energy production and DNA repair, and nicotinamide riboside reliably raises blood NAD+ in human trials. That is a reason some owners choose it as general daily cellular support. It is not a reason to choose it for a dog with cognitive decline, and it is not a substitute for the veterinary appointment described above.

Other strategies that support an aging dog

• Mental stimulation: puzzle toys, short training sessions, interactive games
• Regular exercise: supports blood flow and general wellbeing
• Consistent routine: reduces the anxiety and confusion that come with disorientation
• Environmental enrichment: comfortable bedding, familiar toys, safe access to outdoor space
• Night-time adjustments: night lights and blocked-off stairs help a disoriented dog stay safe

Choosing supplements, if you choose any

• Ask what the canine evidence is. Not human, not rodent, not in vitro. If the answer is vague, that is the answer.
• A printed per-ingredient dose, never a proprietary blend.
• Third-party testing for potency and purity, and cGMP manufacturing.
• Tell your veterinarian what you are giving. Supplements interact with medication, and a dog being worked up for CCD is often on other drugs.

Frequently asked questions

Do any supplements actually treat dog dementia?

No supplement is a treatment for canine cognitive dysfunction, and none has been shown to stop or reverse it. The strongest canine evidence in this area is for antioxidant-enriched therapeutic diets, tested in aged beagles in controlled studies. Those are diets prescribed through your veterinarian, not shelf supplements. Anything sold to you as a dementia supplement that "works" is ahead of the evidence.

Do NAD+ precursors help dog dementia?

No. No published canine study shows an NAD+ precursor improving cognition. The one canine trial often cited combined a senolytic with a precursor, did not measure NAD+, and showed no significant benefit on objective cognitive testing. All three human trials of nicotinamide riboside that measured cognition were null, at five to ten times the dose used in dog products. We sell an NAD+ precursor and we are telling you it is not a dementia product.

What should I do if my dog is showing signs of dementia?

See your veterinarian. Disorientation, altered sleep-wake cycles, loss of housetraining and reduced interaction can all be caused by pain, sensory loss, endocrine disease, hypertension or a brain lesion, and several of those are treatable. CCD is a diagnosis of exclusion, so the diagnosis comes first. There is a licensed veterinary medication for CCD in dogs, and prescription therapeutic diets with canine trial data behind them. Both come from your vet.

What actually has evidence in aging dogs?

Controlled studies in aged beagles found that diets enriched with antioxidants improved performance on cognitive tasks, and that behavioral enrichment added to the effect. Environmental enrichment, mental stimulation, consistent routine and regular exercise are supported alongside diet. That combination is where the canine evidence actually sits.

Conclusion

Dog dementia is hard, and the wish for something that helps is completely understandable. That wish is also what the supplement category sells into. The honest position today: get the diagnosis, ask your vet about a therapeutic diet and about licensed medication, build the enrichment and routine around your dog, and treat any supplement as an unproven addition rather than a treatment. If your dog is showing signs of confusion or disorientation, book the appointment. That is the step that changes outcomes.

This article is for informational purposes only. It is not, nor is it intended to be, a substitute for professional medical or veterinary advice, diagnosis, or treatment and should never be relied upon or perceived as specific medical or veterinary advice.

References

Araujo, J. A., Studzinski, C. M., Head, E., Cotman, C. W., & Milgram, N. W. (2005). Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. The Journal of Nutritional Biochemistry, 16(10), 627–635.

Heath, S. E., Barabas, S., & Craze, P. G. (2007). Nutritional supplementation in cases of canine cognitive dysfunction — a clinical trial. Journal of the American Animal Hospital Association, 43(5), 275–283.

Pan, Y., Landsberg, G., Mougeot, I., et al. (2018). Efficacy of a therapeutic diet on dogs with signs of cognitive dysfunction syndrome. Frontiers in Nutrition, 5, 127.

McKay, K., et al. (2024). Randomized controlled trial of a senolytic plus an NAD+ precursor combination in senior dogs. Scientific Reports, 14. — objective cognitive testing showed no significant difference; the trial did not measure NAD+ and did not isolate the precursor.